Prosecution Insights
Last updated: November 04, 2026
Application No. 18/091,172

Microcatheter path generation method, shaping method of mandrel, computer equipment, readable storage medium and program product

Non-Final OA §101§103§112
Filed
Dec 29, 2022
Priority
Dec 31, 2021 — CN 2021116638807
Examiner
LI, JOHN DENNY
Art Unit
3798
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Hangzhou Arteryflow Technology Co. Ltd.
OA Round
1 (Non-Final)
64%
Grant Probability
Moderate
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 64% of resolved cases
64%
Career Allowance Rate
172 granted / 270 resolved
-6.3% vs TC avg
Strong +48% interview lift
Without
With
+48.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
36 currently pending
Career history
315
Total Applications
across all art units

Statute-Specific Performance

§101
6.3%
-33.7% vs TC avg
§103
48.0%
+8.0% vs TC avg
§102
12.5%
-27.5% vs TC avg
§112
30.4%
-9.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 270 resolved cases

Office Action

§101 §103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Invention I, Species B in the reply filed on 9/24/2026 is acknowledged. Claims 2, 4-7, 11, 13-16, and 18-20 withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention and species, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 9/24/2026. Claim Objections Claim is objected to because of the following informalities: In claim 1; “a improved microcatheter path” should be changed to “an improved microcatheter path” for grammar. In claim 1; “intracranial vascular model with aneurysm” should be changed to “intracranial vascular model with an aneurysm” for grammar. In claim 1; “the generation methods of each unit segment” should be changed to “the generation method[[s]] of each unit segment” for grammar. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1, 3, 8-10, 12, and 17 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Regarding claim 1, claim 1 recites “according to the offset vector, the nearest point and its follow-up points on the centerline toward the distal end are offset in sequence until a critical point that does not exceed the vessel wall after the offset is found”. This is understood to be a computer implemented functional limitation which requires disclosure of the underlying algorithm(s) for obtaining the result in order to comply with the written description requirement. See MPEP § 2161.01(1). While the specification provides literal support for finding a critical point as in [0011], [0046], [0051], [0078], [0089], [0100] (paragraphs as numbered in applicant's pre-grant publication, US20230210600A1), there is no description as to how the offset vector, nearest point, and its follow up points are used to determine a critical point, how they are used to offset in sequence, or what they are offsetting. Additionally, there is no description of what a follow-up point is at all other than it is used to determine the critical point nor is there any description of how to generate the offset vector or the follow-up points. For this reason, applicant has failed to comply with the written description requirement for this computer-implemented function. Regarding claim 1, claim 1 recites “according to the offset vector, the nearest point and its follow-up points on the centerline toward the distal end are offset in sequence until a critical point that does not exceed the vessel wall after the offset is found”. While the specification provides literal support for finding a critical point as in [0011], [0046], [0051], [0078], [0089], [0100] (paragraphs as numbered in applicant's pre-grant publication, US20230210600A1), there is no description as to how the offset vector, nearest point, and its follow up points are used to determine a critical point, how they are used to offset in sequence, or what they are offsetting. Additionally, there is no description of what a follow-up point is at all other than it is used to determine the critical point nor is there any description of how to generate the offset vector or the follow-up points. The Applicant’s description appears to be a black box in which undefined variables are input and a desired result is generated with no description for how the variables are determined and what is done to obtain the desired result. For this reason, applicant has failed to demonstrate that at the time the application was filed, they had possession of the claimed invention. Regarding claim 3, claim 3 recites “restricting the points within the blood vessel wall through offsetting the points beyond the blood vessel wall, and connecting them sequentially to generate the curved segments”. This is understood to be a computer implemented functional limitation which requires disclosure of the underlying algorithm(s) for obtaining the result in order to comply with the written description requirement. See MPEP § 2161.01(1). While the specification provides literal support for finding a critical point as in [0016], [0069] (paragraphs as numbered in applicant's pre-grant publication, US20230210600A1), there is no description as to how the points are restricted via offsetting points. Additionally, there is no description of what an offsetting point is nor is there any description of how to generate the offsetting points. For this reason, applicant has failed to comply with the written description requirement for this computer-implemented function. Regarding claim 3, claim 3 recites “restricting the points within the blood vessel wall through offsetting the points beyond the blood vessel wall, and connecting them sequentially to generate the curved segments”. While the specification provides literal support for finding a critical point as in [0016], [0069] (paragraphs as numbered in applicant's pre-grant publication, US20230210600A1), there is no description as to how the points are restricted via offsetting points. Additionally, there is no description of what an offsetting point is nor is there any description of how to generate the offsetting points. The Applicant’s description appears to be a black box in which undefined variables are input and a desired result is generated with no description for how the variables are determined and what is done to obtain the desired result. For this reason, applicant has failed to demonstrate that at the time the application was filed, they had possession of the claimed invention. Regarding claim 12, claim 12 recites “restricting the points within the blood vessel wall through offsetting the points beyond the blood vessel wall, and connecting them sequentially to generate the curved segments”. This is understood to be a computer implemented functional limitation which requires disclosure of the underlying algorithm(s) for obtaining the result in order to comply with the written description requirement. See MPEP § 2161.01(1). While the specification provides literal support for finding a critical point as in [0016], [0069] (paragraphs as numbered in applicant's pre-grant publication, US20230210600A1), there is no description as to how the points are restricted via offsetting points. Additionally, there is no description of what an offsetting point is nor is there any description of how to generate the offsetting points. For this reason, applicant has failed to comply with the written description requirement for this computer-implemented function. Regarding claim 12, claim 12 recites “restricting the points within the blood vessel wall through offsetting the points beyond the blood vessel wall, and connecting them sequentially to generate the curved segments”. While the specification provides literal support for finding a critical point as in [0016], [0069] (paragraphs as numbered in applicant's pre-grant publication, US20230210600A1), there is no description as to how the points are restricted via offsetting points. Additionally, there is no description of what an offsetting point is nor is there any description of how to generate the offsetting points. The Applicant’s description appears to be a black box in which undefined variables are input and a desired result is generated with no description for how the variables are determined and what is done to obtain the desired result. For this reason, applicant has failed to demonstrate that at the time the application was filed, they had possession of the claimed invention. Regarding claim 17, claim 17 recites “restricting the points within the blood vessel wall through offsetting the points beyond the blood vessel wall, and connecting them sequentially to generate the curved segments”. This is understood to be a computer implemented functional limitation which requires disclosure of the underlying algorithm(s) for obtaining the result in order to comply with the written description requirement. See MPEP § 2161.01(1). While the specification provides literal support for finding a critical point as in [0016], [0069] (paragraphs as numbered in applicant's pre-grant publication, US20230210600A1), there is no description as to how the points are restricted via offsetting points. Additionally, there is no description of what an offsetting point is nor is there any description of how to generate the offsetting points. For this reason, applicant has failed to comply with the written description requirement for this computer-implemented function. Regarding claim 17, claim 17 recites “restricting the points within the blood vessel wall through offsetting the points beyond the blood vessel wall, and connecting them sequentially to generate the curved segments”. While the specification provides literal support for finding a critical point as in [0016], [0069] (paragraphs as numbered in applicant's pre-grant publication, US20230210600A1), there is no description as to how the points are restricted via offsetting points. Additionally, there is no description of what an offsetting point is nor is there any description of how to generate the offsetting points. The Applicant’s description appears to be a black box in which undefined variables are input and a desired result is generated with no description for how the variables are determined and what is done to obtain the desired result. For this reason, applicant has failed to demonstrate that at the time the application was filed, they had possession of the claimed invention. The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1, 3, 8-10, 12, 17 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claims 1, 3, 8-10, 12, 17, the claims are generally narrative and indefinite, failing to conform with current U.S. practice. They appear to be a literal translation into English from a foreign document and are replete with grammatical and idiomatic errors. Regarding claim 1, the limitation “the intracranial vascular model with aneurysm” lacks antecedent basis. Regarding claim 1, the limitation “the proximal vessel entrance” lacks antecedent basis. Regarding claim 1, the limitation “the distal aneurysm” lacks antecedent basis. Regarding claim 1, the limitation “the proximal start point” lacks antecedent basis. Regarding claim 1, the limitation “the proximal starting point” lacks antecedent basis. It is also unclear how this proximal starting point relates to the proximal start point. Regarding claim 1, the limitation “the blood vessel” lacks antecedent basis. Regarding claim 1, the limitation “the vessel wall” lacks antecedent basis. It is also unclear how this vessel wall relates to the inner wall of the blood vessel previously set forth. Regarding claim 1, the limitation “the nearest point” lacks antecedent basis. It is also unclear how this nearest point relates to the closest point previously set forth. Regarding claim 1, the limitation “the curved section” lacks antecedent basis. It is also unclear how this curve section relates to the curved segment previously set forth. Regarding claim 1, claim 1 recites “according to the offset vector, the nearest point and its follow-up points on the centerline toward the distal end are offset in sequence until a critical point that does not exceed the vessel wall after the offset is found”. It is unclear how the offset vector, nearest point, and its follow up points are used to determine a critical point, how they are used to offset in sequence, or what they are offsetting because there is no description of what a follow-up point is in the specification. Clarification is required. Regarding claim 3, claim 3 recites “restricting the points within the blood vessel wall through offsetting the points beyond the blood vessel wall, and connecting them sequentially to generate the curved segments”. It is unclear what restricting the points or offsetting the points means because there is no description in the specification of what the process is. Clarification is required. Regarding claim 3, the limitation “the generation approach” lacks antecedent basis. It is also unclear how this generation approach relates to the generation method previously set forth. Regarding claim 3, the limitation “the blood vessel wall” lacks antecedent basis. It is also unclear how this blood vessel wall relates to the inner wall of the blood vessel and the vessel wall previously set forth. Regarding claim 3, the limitation “the points” has unclear antecedent basis. It is also unclear how this blood vessel wall relates to the inner wall of the blood vessel and unclear if this limitation is referring to the nearest point, closest point, follow-up point, proximal start point, proximal starting point, distal end point, middle demarcation point, contact point, or some other point. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 8-10 are rejected under 35 U.S.C. 101 because the claimed invention is directed to non-statutory subject matter. The claim(s) does/do not fall within at least one of the four categories of patent eligible subject matter because their broadest reasonable interpretation includes signals per se. See MPEP 2106.03(I). To overcome this rejection the Examiner recommends amending the claims to recite “non-transitory”. Claims 1, 3, 8-10, 12, 17 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea in the form of a mental process without significantly more. Regarding claim 1, claim 1 is considered to be directed towards an abstract idea because they recite a mental process of generating a centerline and a plurality of unit segments to form a microcatheter path. Specifically, the limitation of calculating a centerline and a plurality of unit segments to form a microcatheter path is a process that, under its broadest reasonable interpretation, covers performance of the limitation in the mind. That is, nothing in the claim element precludes the step from practically being performed in the mind. If a claim limitation, under its broadest reasonable interpretation, covers performance of the limitation in the mind, then it falls within the “mental processes” grouping of abstract ideas. See MPEP § 2106.04(a)(2).III. A-B. The judicial exceptions enumerated above (i.e., mathematical formula, mental process, and law of nature) are not integrated into a practical application. Specifically, the additional limitations of claim 1 directed towards acquiring an intracranial vascular model are merely extra-solution activity of gathering data that would be required in any form of data analysis to implement the judicial exceptions. Consequently, these additional elements do not integrate the judicial exceptions into a practical application because they do not impose any meaningful limits on practicing the judicial exceptions. The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception. For example, as explained above, the additional limitations of claim 1 directed towards acquiring an intracranial vascular model are merely extra-solution activity of gathering data that would be required in any form of data analysis to implement the judicial exceptions. Mere extra-solution activity does not add significantly more to the judicial exceptions. Therefore, when considered separately and in combination, the additional limitations of claim 1 do not add significantly more (also known as an “inventive concept”) to the judicial exceptions. Turning to the dependent claims: Claims 3, 12, and 17 recite additional elements directed towards further details of the abstract idea, specifying particular calculations used to implement the abstract idea of calculating the unit segments. These elements are not integrated into a practical application and are insufficient to amount to “significantly more” than the abstract idea because they too are directed towards the abstract idea. Claims 8-10 recites additional elements directed towards processing circuitry or use thereof comprise no more than instructions to implement the judicial exceptions on a computer, or merely use a computer as a tool to perform the judicial exceptions. Mere instructions to apply an exception using generic computer components do not integrate the judicial exception into a practical application and do not add significantly more to the judicial exceptions. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 3, 8-10, 12, 17 are rejected under 35 U.S.C. 103 as being unpatentable over Wang et al. (CN112419276B, hereafter Wang and using a machine translation) and Kumar (WO2015150320A1). Regarding claim 1, Wang discloses an improved microcatheter path generation method, comprising: acquiring the intracranial vascular model with aneurysm (Wang, Pg 3; “To achieve the above object, in a first aspect, the present application provides a method for adjusting a contour of a blood vessel, comprising: acquiring a blood vessel central line and a blood vessel contour line of a two-dimensional coronary angiography;”), generating the centerline from the proximal vessel entrance to the distal aneurysm (Wang, Pg 3; “selecting an adjustment region of the vessel contour line of interest; and adjusting the blood vessel contour line in the adjusting area to be close to or far from the blood vessel center line to obtain a blood vessel correction contour line. Optionally, in the method for adjusting a blood vessel contour, the method for adjusting the blood vessel contour line in the adjusting area to be close to or far from the blood vessel center line to obtain the corrected blood vessel contour line includes:”), and determining the proximal start point, distal end point, and middle demarcation point of the centerline, wherein a plurality of unit segments are sequentially generated from the proximal starting point toward the distal aneurysm, and the unit segments include a straight line segment and a curved segment connected in sequence, and each unit segment is connected in sequence (Wang, Pg 3; “obtaining a single adjustment step length m; selecting any point in a 1/3-2/3 area in the adjustment area as an original contour point; acquiring a point which corresponds to the original contour point and is positioned on the blood vessel central line as a corresponding central point; obtaining a unit vector and Euclidean distance between the original contour point and the corresponding center point; the original contour point moves a plurality of steps along the unit vector to obtain a contour adjusting point;”), the generation methods of each unit segment include: obtaining the starting point of the straight line segment and the slope of the straight line segment, and continuously extending the straight line segment from the starting point of the straight line segment along the slope of the straight line segment until the straight line segment touches the inner wall of the blood vessel to obtain a contact point; wherein the contact point is the starting point of the curved segment, and the closest point with the closest distance to the contact point is selected on the centerline to obtain an offset vector directed from the closest point to the contact point; and according to the offset vector, the nearest point and its follow-up points on the centerline toward the distal end are offset in sequence until a critical point that does not exceed the vessel wall after the offset is found, and the critical point is the end point of the curved section (Wang, Pg 4; “and in the adjustment area, picking up a starting point, a contour adjustment point, a plurality of seed points and an end point of the blood vessel contour line, and adopting a cubic B spline fitting curve algorithm to fit to obtain a blood vessel correction contour line. Optionally, the method for adjusting the profile of a blood vessel further comprises: and correcting and adjusting the blood vessel correction contour line. Optionally, the method for adjusting the profile of the blood vessel, the method for correcting and adjusting the profile line of the blood vessel comprises the following steps: acquiring an included angle alpha of an original contour point, a corresponding center point and a contour adjusting point on the contour line of the blood vessel; acquiring Euclidean distance L between the corresponding center point and the profile adjusting point; if said alpha > 90 DEG or L < D min Acquiring a contour replacement point according to the unit vector of the original contour point and the corresponding center point, the original contour point coordinate, the minimum vessel diameter and the corresponding center point coordinate; if said alpha is not more than 90 DEG and L is not less than D min Taking the profile adjusting point as a wheel buckle replacing point; and in the adjustment area, picking up a starting point, a profile replacement point, a plurality of seed points and an end point of the blood vessel profile line, and adopting a cubic B spline fitting curve algorithm to fit to obtain a new blood vessel correction profile line.”). Wang is interpreted as disclosing these limitations in the claim as best understood by the Examiner in view of the 112 deficiencies outlined above. Wang does not clearly and explicitly disclose using the segments to form at least a part of the microcatheter path. In an analogous vessel modeling field of endeavor Kumar discloses using vascular segments to form at least a part of a microcatheter path (Kumar, Pg 1; “The human body contains several different types of blood vessels that constitute a network of arteries and veins. Visualization of these blood vessels is important for improving the planning and navigation in several interventional procedures. It is specifically relevant in catheter based procedures like stent graft positioning and valve replacement and also, in planning and navigation of laparoscopic liver resection. […] Along with a segmented model of the blood vessels, centreline and radius information at different cross-sections of the blood vessel are also crucial for navigating the catheter. The centreline of the blood vessels can be used as a guiding path for the catheter and radius information will help the interventionists in selecting the right valve or stent for the specific procedure.”). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Wang to include using the segments to form at least a part of the microcatheter path in order to allow for a fast and useful method for navigating catheters as needed as taught by Kumar (Kumar, Pg 1). Regarding claim 3, 12, and 17, Wang as modified by Kumar above discloses all of the limitations of claim 1 as discussed above. Wang further discloses wherein each unit segment, the generation approach of described curved segment comprises: obtaining the starting point of the curved segment and the end point of the curved segment; and restricting the points within the blood vessel wall through offsetting the points beyond the blood vessel wall, and connecting them sequentially to generate the curved segments (Wang, Pg 4; “and in the adjustment area, picking up a starting point, a contour adjustment point, a plurality of seed points and an end point of the blood vessel contour line, and adopting a cubic B spline fitting curve algorithm to fit to obtain a blood vessel correction contour line. Optionally, the method for adjusting the profile of a blood vessel further comprises: and correcting and adjusting the blood vessel correction contour line. Optionally, the method for adjusting the profile of the blood vessel, the method for correcting and adjusting the profile line of the blood vessel comprises the following steps: acquiring an included angle alpha of an original contour point, a corresponding center point and a contour adjusting point on the contour line of the blood vessel; acquiring Euclidean distance L between the corresponding center point and the profile adjusting point; if said alpha > 90 DEG or L < D min Acquiring a contour replacement point according to the unit vector of the original contour point and the corresponding center point, the original contour point coordinate, the minimum vessel diameter and the corresponding center point coordinate; if said alpha is not more than 90 DEG and L is not less than D min Taking the profile adjusting point as a wheel buckle replacing point; and in the adjustment area, picking up a starting point, a profile replacement point, a plurality of seed points and an end point of the blood vessel profile line, and adopting a cubic B spline fitting curve algorithm to fit to obtain a new blood vessel correction profile line.”). Wang is interpreted as disclosing these limitations in the claim as best understood by the Examiner in view of the 112 deficiencies outlined above. Regarding claim 8, Wang as modified by Kumar above discloses all of the limitations of claim 1 as discussed above. Wang further discloses a computer equipment, comprising a memory, a processor and a computer program stored on the memory, wherein the processor executes the computer program to realize the steps of improved microcatheter path generation method according to claim 1 (Wang, Pg 5; “In a third aspect, the present application provides a computer storage medium, and when the computer program is executed by a processor, the above-mentioned method for adjusting the contour of a blood vessel is implemented.”). Regarding claim 9, Wang as modified by Kumar above discloses all of the limitations of claim 1 as discussed above. Wang further discloses a computer-readable storage medium on which a computer program is stored, wherein the computer program is executed by a processor to realize the steps of improved microcatheter path generation method according to claim 1 (Wang, Pg 5; “In a third aspect, the present application provides a computer storage medium, and when the computer program is executed by a processor, the above-mentioned method for adjusting the contour of a blood vessel is implemented.”). Regarding claim 10, Wang as modified by Kumar above discloses all of the limitations of claim 1 as discussed above. Wang further discloses a computer program product, comprising computer instructions, wherein the computer instructions are executed by a processor to realize the steps of improved microcatheter path generation method according to claim 1 (Wang, Pg 5; “In a third aspect, the present application provides a computer storage medium, and when the computer program is executed by a processor, the above-mentioned method for adjusting the contour of a blood vessel is implemented.”). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to John Li whose telephone number is (313)446-4916. The examiner can normally be reached Monday to Thursday; 5:30 AM to 3:30 PM Eastern. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Pascal Bui-Pho can be reached at (571) 272-2714. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOHN D LI/Primary Examiner, Art Unit 3798
Read full office action

Prosecution Timeline

Dec 29, 2022
Application Filed
Oct 21, 2026
Non-Final Rejection mailed — §101, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12765912
DEVICE AND METHOD FOR AUTOMATED INSERTION OF PENETRATING MEMBER
2y 12m to grant Granted Oct 20, 2026
Patent 12766366
SYSTEM FOR PROVIDING GUIDED AND MONITORED EXERCISE ROUTINES
1y 9m to grant Granted Oct 20, 2026
Patent 12733907
Transducer Array Device, Method and System for Cardiac Conditions
2y 10m to grant Granted Sep 15, 2026
Patent 12727859
METHOD AND APPARATUS FOR PERFORMING SPECTRAL DOPPLER IMAGING
3y 5m to grant Granted Sep 08, 2026
Patent 12721590
Closed-Loop Control of Heart Failure Interventional Therapy
4y 5m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
64%
Grant Probability
99%
With Interview (+48.0%)
3y 3m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 270 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month